Régulation émotionnelle

The association of ADHD and ADHD medication with adherence to pharmacotherapy for type 2 diabetes: a population-based cohort study from seven countries.

Zhou Y, Yao H, Xie T, Gillies MB, Zhang-James Y, Brikell I, Engeland A, Gao L, Semark BD, Wimberley T, Astrup A, Dong Z, Sarsembayeva D, Vos M, Yuen ASC, Dalsgaard S, Faraone SV, Klungsøyr K, Larsson H, Man KKC, Wong ICK, Zoega H, Snieder H, Chang Z, Hartman CA

EClinicalMedicine . 2026;99 :104182

📅 01/09/2026 PMID : 42724543 DOI : 10.1016/j.eclinm.2026.104182

Résumé

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) may compromise adherence to pharmacotherapy in adults with type 2 diabetes, but the relationship is unknown. We investigated the association of ADHD and ADHD medication with antidiabetic medication adherence in multinational cohort data.METHODS: Using a common analytical protocol and population-based databases from seven countries, we identified adults initiating non-insulin antidiabetic medication between 2010 and 2020. ADHD was identified by diagnosis or ADHD medication use. We used the proportion of days covered (PDC) to measure antidiabetic medication adherence and defined the primary outcome, poor adherence, as PDC